Sequoia Financial Advisors, LLC Novo Nordisk A S Transaction History

Sequoia Financial Advisors, LLC

$11.5 Billion
Q4 2024

A detailed history of Sequoia Financial Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 31,670 shares of NVO stock, worth $1.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

31,670

Previous 31,519 0.48%

Holding current value

$1.9 Million

Previous $3.75 Million 27.4%

% of portfolio

0.02%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$85.0 - $120.04 $12,835 - $18,126	151 Added 0.48%	31,670 $2.72 Million
Q3 2024 Oct 21, 2024	SELL	$119.07 - $145.42 $36,911 - $45,080	-310 Reduced 0.97%	31,519 $3.75 Million
Q2 2024 Jul 15, 2024	BUY	$122.71 - $146.91 $171,057 - $204,792	1,394 Added 4.58%	31,829 $4.54 Million
Q1 2024 Apr 30, 2024	SELL	$102.11 - $135.92 $1.11 Million - $1.48 Million	-10,898 Reduced 26.37%	30,435 $3.91 Million
Q4 2023 Jan 25, 2024	BUY	$87.78 - $105.45 $1.12 Million - $1.34 Million	12,733 Added 44.52%	41,333 $4.28 Million
Q3 2023 Nov 08, 2023	BUY	$90.94 - $199.54 $1.33 Million - $2.92 Million	14,610 Added 104.43%	28,600 $2.6 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $441,579 - $488,772	2,831 Added 25.37%	13,990 $2.26 Million
Q1 2023 Apr 24, 2023	BUY	$132.34 - $159.14 $111,033 - $133,518	839 Added 8.13%	11,159 $1.78 Million
Q4 2022 Jan 17, 2023	BUY	$102.55 - $135.33 $479,934 - $633,344	4,680 Added 82.98%	10,320 $0
Q3 2022 Oct 26, 2022	SELL	$95.28 - $116.93 $97,185 - $119,268	-1,020 Reduced 15.32%	5,640 $562,000
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $83,624 - $98,666	810 Added 13.85%	6,660 $742,000
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $87,979 - $106,350	945 Added 19.27%	5,850 $650,000
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $470,291 - $574,277	4,905 New	4,905 $549,000
Q3 2021 Oct 26, 2021	SELL	$84.42 - $106.62 $242,876 - $306,745	-2,877 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$67.66 - $84.76 $194,657 - $243,854	2,877 New	2,877 $241,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $195,077 - $220,560	-2,909 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $10,222 - $11,808	-160 Reduced 5.21%	2,909 $203,000
Q3 2020 Oct 23, 2020	BUY	$63.69 - $70.22 $195,464 - $215,505	3,069 New	3,069 $213,000

Others Institutions Holding NVO

# of Institutions

1,861

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $135B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.

Account

Sequoia Financial Advisors, LLC Novo Nordisk A S Transaction History